Literature DB >> 12670953

Reversion of the lethal phenotype of an HIV-1 integrase mutant virus by overexpression of the same integrase mutant protein.

Stéphane Priet1, Jean-Marc Navarro, Gilles Quérat, Joséphine Sire.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) integrase (IN) is essential for integration of viral DNA into host cell chromatin. We have reported previously (Priet, S., Navarro, J. M., Gros, N., Querat, G., and Sire, J. (2003) J. Biol. Chem. 278, 4566-4571) that IN also plays a role in the packaging of the host uracil DNA glycosylase UNG2 into viral particles and that the region of IN encompassing residues 170-180 was responsible for the interaction with UNG2 and for its packaging into virions. In this work, we aimed to investigate the replication of HIV-1 viruses rendered deficient in virion-associated UNG2 by single or double point mutations in the region 170-180 of IN. We show that the L172A/K173A IN mutant virus was deficient for UNG2 packaging and was defective for replication because of a blockage at the stage of proviral DNA integration in host cell DNA. In vitro assays using long term repeat mimics, however, demonstrate that the L172A/K173A IN mutant was catalytically active. Moreover, trans-complementation experiments show that the viral propagation of L172A/K173A viruses could be rescued by the overexpression of Vpr.L172A/K173A IN fusion protein in a dose-dependent manner and that this rescue is independent of UNG2 packaging. Altogether, our data indicate that L172A/K173A mutations of IN induce a subtle defect in the function of IN, which nevertheless dramatically impairs viral replication. Unexpectedly, this blockage of replication could be overcome by forcing the packaging of higher amounts of this same mutated integrase. This is the first study reporting that blockage of the integration process of HIV-1 provirus carrying a mutation of IN could be alleviated by increasing amounts of IN even carrying the same mutations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670953     DOI: 10.1074/jbc.M301768200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Retroviral reverse transcriptases.

Authors:  Alon Herschhorn; Amnon Hizi
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

2.  Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type 1 integrase.

Authors:  Richard Lu; Ana Limón; Hina Z Ghory; Alan Engelman
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Genetic analyses of conserved residues in the carboxyl-terminal domain of human immunodeficiency virus type 1 integrase.

Authors:  Richard Lu; Hina Z Ghory; Alan Engelman
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Lys-34, dispensable for integrase catalysis, is required for preintegration complex function and human immunodeficiency virus type 1 replication.

Authors:  Richard Lu; Nick Vandegraaff; Peter Cherepanov; Alan Engelman
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Characterization of the HIV-1 integrase chromatin- and LEDGF/p75-binding abilities by mutagenic analysis within the catalytic core domain of integrase.

Authors:  Yingfeng Zheng; Zhujun Ao; Kallesh Danappa Jayappa; Xiaojian Yao
Journal:  Virol J       Date:  2010-03-23       Impact factor: 4.099

6.  Identification of an inhibitor-binding site to HIV-1 integrase with affinity acetylation and mass spectrometry.

Authors:  Nick Shkriabai; Sachindra S Patil; Sonja Hess; Scott R Budihas; Robert Craigie; Terrence R Burke; Stuart F J Le Grice; Mamuka Kvaratskhelia
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

7.  Defining the DNA substrate binding sites on HIV-1 integrase.

Authors:  James Dolan; Aiping Chen; Irene T Weber; Robert W Harrison; Jonathan Leis
Journal:  J Mol Biol       Date:  2008-11-07       Impact factor: 5.469

8.  Class II integrase mutants with changes in putative nuclear localization signals are primarily blocked at a postnuclear entry step of human immunodeficiency virus type 1 replication.

Authors:  Richard Lu; Ana Limón; Eric Devroe; Pamela A Silver; Peter Cherepanov; Alan Engelman
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 9.  Uracil within DNA: an actor of antiviral immunity.

Authors:  Joséphine Sire; Gilles Quérat; Cécile Esnault; Stéphane Priet
Journal:  Retrovirology       Date:  2008-06-05       Impact factor: 4.602

10.  Uracil DNA Glycosylase 2 negatively regulates HIV-1 LTR transcription.

Authors:  David Fenard; Laurent Houzet; Eric Bernard; Audrey Tupin; Sonia Brun; Marylène Mougel; Christian Devaux; Nathalie Chazal; Laurence Briant
Journal:  Nucleic Acids Res       Date:  2009-08-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.